HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuma Isshiki Selected Research

Neoplasms (Cancer)

1/2020Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma.
9/2018Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression.
12/2017Cutting Edge: Anti-TIM-3 Treatment Exacerbates Pulmonary Inflammation and Fibrosis in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuma Isshiki Research Topics

Disease

11Idiopathic Pulmonary Fibrosis
12/2023 - 01/2015
5Interstitial Lung Diseases (Interstitial Lung Disease)
12/2023 - 01/2018
4Sarcoidosis (Schaumann Disease)
08/2021 - 01/2013
3Fibrosis (Cirrhosis)
01/2023 - 12/2017
3Neoplasms (Cancer)
01/2020 - 12/2017
3Inflammation (Inflammations)
05/2019 - 01/2015
2Lung Diseases (Lung Disease)
12/2023 - 11/2020
2Trichosporonosis
09/2023 - 11/2020
2Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
09/2023 - 11/2020
2Lung Neoplasms (Lung Cancer)
07/2021 - 01/2020
2Pneumonia (Pneumonitis)
12/2017 - 08/2015
1Disease Progression
12/2023
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2023
1Systemic Vasculitis
10/2023
1Microscopic Polyangiitis
10/2023
1Wounds and Injuries (Trauma)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021
1Circulating Neoplastic Cells
07/2021
1Pulmonary Sarcoidosis
11/2020
1Adenocarcinoma of Lung
01/2020
1Rheumatoid Arthritis
05/2019
1Thymoma (Thymic Carcinoma)
09/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2018
1Bronchiectasis
02/2018
1Acute Lung Injury
01/2018
1Hypoxia (Hypoxemia)
11/2017
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2017

Drug/Important Bio-Agent (IBA)

4ThrombomodulinIBA
05/2019 - 01/2015
3Antifibrotic AgentsIBA
12/2023 - 02/2018
3Proteins (Proteins, Gene)FDA Link
05/2019 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
07/2021 - 01/2020
2PeriostinIBA
05/2021 - 11/2020
2pirfenidoneIBA
03/2021 - 01/2017
1Connective Tissue Growth FactorIBA
12/2023
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2023
1Tacrolimus (Prograf)FDA LinkGeneric
01/2023
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023
1MicroRNAs (MicroRNA)IBA
01/2022
1CollagenIBA
01/2022
1Collagen Type I (Type I Collagen)IBA
01/2022
1Formaldehyde (Formol)FDA Link
08/2021
1Monoclonal AntibodiesIBA
08/2021
1ParaffinIBA
08/2021
1osimertinibIBA
07/2021
1Messenger RNA (mRNA)IBA
07/2021
1CC ChemokinesIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1Matrix Metalloproteinase 7 (Matrilysin)IBA
11/2020
1LigandsIBA
11/2020
1Phosphotransferases (Kinase)IBA
01/2020
1InterleukinsIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Gefitinib (Iressa)FDA Link
01/2020
1ThrombinFDA Link
05/2019
1Complement System Proteins (Complement)IBA
05/2019
1Etanercept (Enbrel)FDA Link
05/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2019
1B7-H1 AntigenIBA
09/2018
1pembrolizumabIBA
09/2018
1HMGB1 Protein (HMG1)IBA
01/2018
1Immune Checkpoint InhibitorsIBA
12/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2017
1Immunoglobulin G (IgG)IBA
12/2017
1Interleukin-13IBA
08/2015
1Cysteine Proteases (Cysteine Protease)IBA
08/2015
1CytokinesIBA
08/2015
1Interleukin-5 (Interleukin 5)IBA
08/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2013
1Methotrexate (Mexate)FDA LinkGeneric
01/2013
1Cytotoxins (Cytolysins)IBA
01/2013

Therapy/Procedure

3Therapeutics
01/2020 - 09/2018
2Humidifiers
09/2023 - 11/2020
1Drug Therapy (Chemotherapy)
09/2018
1Traction
02/2018
1Immunotherapy
12/2017
1Activities of Daily Living (ADL)
11/2017
1Aftercare (After-Treatment)
11/2017